Company Financials

PharmaBlock Sciences Financials

Renminbi

business PharmaBlock Sciences Company Profile

Main Stock Listing

SZSE: 300725

Market Capitalization CN¥9.37 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 38.56
Forward PE 30.85
Price to Sales TTM CN¥4.55
Price to Book MRQ CN¥1.08
Enterprise to Revenue 3.51
Enterprise to EBITDA 18.05

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 10.16%
Operating Margin 18.94%
Return on Assets TTM 2.41%
Return on Equity TTM 4.00%

Income Statement

Revenue TTM CN¥1,979,782,016
Revenue per Share TTM CN¥9.83
Quarterly Revenue Growth 30.40%
Gross Profit TTM CN¥573,893,440
EBITDA CN¥342,048,358
Net Income to Common TTM CN¥201,139,648
Diluted EPS TTM CN¥1.00
Quarterly Earnings Growth YoY 23.50%

Balance Sheet

Total Cash MRQ CN¥903,797,696
Total Cash per Share MRQ CN¥4.50
Total Debt MRQ CN¥
Total Debt to Equity MRQ 1.45
Current Ratio MRQ 4.59
Book Value per Share MRQ CN¥35.58

Cash Flow

Operating Cash Flow TTM CN¥657,427,968
Levered Free Cash Flow TTM CN¥517,774,432

300725 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 199,730,378
Float Shares 155,397,548
Avg 10 Volume 3,663,795
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 24.61%
% Held by Institutions 4.36%

Stock Price Summary

Beta 0.82
Fifty Two Week Low CN¥27.07
Fifty Two Week High CN¥53.54
Fifty Two Week Change 19.06%
Day 50 MA CN¥39.21
Day 200 MA CN¥38.82

Dividends and Splits

Forward Annual Dividend Rate CN¥1.12
Forward Annual Dividend Yield 2.90%
Trailing Annual Dividend Rate CN¥0.28
Trailing Annual Dividend Yield 0.73%
Payout Ratio 27.97%
Dividend Date
Ex Dividend Date 2025-05-30
Last Split Factor
Last Split Date 2021-04-26